Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials

Open Access

Peer-reviewed

Research Article

Bin Wu ,

Contributed equally to this work with: Bin Wu, Haixiang Wu

Affiliation Department of Pharmacy, Ren Ji Hospital, affiliated with the School of Medicine, Shanghai Jiao tong University, Shanghai, China
⨯
Haixiang Wu ,

Contributed equally to this work with: Bin Wu, Haixiang Wu

Affiliation Department of Ophthalmology, and Visual Science, Eye, and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China
⨯
Xiaoyan Liu,

Affiliation Department of Pharmacy, Ren Ji Hospital, affiliated with the School of Medicine, Shanghai Jiao tong University, Shanghai, China
⨯
Houwen Lin,

Affiliation Department of Pharmacy, Ren Ji Hospital, affiliated with the School of Medicine, Shanghai Jiao tong University, Shanghai, China
⨯
Jin Li

* E-mail: wbwithtg@hotmail.com

Affiliation Department of Ophthalmology, Ren Ji Hospital, affiliated with the School of Medicine, Shanghai Jiao tong University, Shanghai, China
⨯

Reader Comments (0)

Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Visual acuity
Is the Subject Area "Visual acuity" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Ophthalmology
Is the Subject Area "Ophthalmology" applicable to this article?

Thanks for your feedback.
Vasculogenesis
Is the Subject Area "Vasculogenesis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.